J. Lontie

发表

Circadian variation of apolipoproteins C-II and C-III and cholesteryl ester metabolism in relation to lipemia in healthy volunteers

T. Magot, C. Malmendier, J. Lontie, 1993 .

Effects of dietary fat modifications on plasma lipid and apolipoprotein metabolism in humans.

C. Malmendier, J. Lontie, 1987, Advances in experimental medicine and biology.

Apolipoproteins C-II and C-III metabolism in hypertriglyceridemic patients. Effect of a drastic triglyceride reduction by combined diet restriction and fenofibrate administration.

L. de Roy, T. Magot, C. Malmendier, 1989, Atherosclerosis.

Mechanisms of hypocholesterolemia.

C. Malmendier, D. Dubois, J. Lontie, 1991, Advances in experimental medicine and biology.

The mutagenicity in procaryotes of insecticides, acaricides, and nematicides.

N. V. van Larebeke, C. Wildemauwe, J. Lontie, 1983, Residue reviews.

In vivo metabolism of apolipoprotein S in humans. Comparison with apolipoprotein A-I metabolism.

C. Malmendier, C. Delcroix, J. Lontie, 1987, Clinica chimica acta; international journal of clinical chemistry.

Kinetics of heterogeneous populations of particles.

C. Delcroix, D. Dubois, J. Lontie, 1991, Advances in experimental medicine and biology.

Metabolism of apolipoprotein C-III in normolipemic human subjects.

C. Malmendier, C. Delcroix, J. Lontie, 1988, Atherosclerosis.

Metabolism of apolipoprotein C: kinetic studies in human subjects: a critical review.

C. Malmendier, C. Delcroix, J. Lontie, 1987, Advances in experimental medicine and biology.

Receptor-dependent and -independent catabolism of low-density lipoprotein in a kindred with familial hypobetalipoproteinemia.

C. Sérougne, J. Férézou, D. M. Lee, 1992, Metabolism: clinical and experimental.

Kinetics of a heterogeneous population of particles in low density lipoprotein apolipoprotein B.

C. Malmendier, C. Delcroix, J. Lontie, 1989, Atherosclerosis.

The effect of combined fenofibrate and cholestyramine therapy on low-density lipoprotein kinetics in familial hypercholesterolemia patients.

C. Malmendier, C. Delcroix, J. Lontie, 1987, Clinica chimica acta; international journal of clinical chemistry.

Metabolism of apolipoprotein C-I in normolipoproteinemic human subjects.

C. Malmendier, C. Delcroix, J. Lontie, 1986, Atherosclerosis.

In vivo metabolism of apolipoproteins A-IV and A-I associated with high density lipoprotein in normolipidemic subjects.

P. Gambert, L. Lagrost, C. Malmendier, 1991, Journal of lipid research.

Metabolism of lipoprotein particle LP-B. Current problems of LP-B in vivo kinetics.

C. Malmendier, C. Delcroix, J. Lontie, 1991, Progress in lipid research.

Alterations in lipoprotein density classes in infantile visceral Leishmaniasis: presence of apolipoprotein SAA

M. Bouma, C. Malmendier, M. Ayrault-Jarrier, 1992, European journal of clinical investigation.

Plasma lipoproteins in infantile visceral leishmaniasis: deficiency of apolipoproteins A-I and A-II.

A. Mebazaa, M. Bouma, C. Malmendier, 1989, Clinica chimica acta; international journal of clinical chemistry.

An improved method for detection of low density lipoprotein receptor defects in human T lymphocytes.

O. Descamps, M. Ronveaux-dupal, F. Heller, 1996, Journal of lipid research.

Lipid and apolipoprotein changes after orthotopic liver transplantation for end-stage liver diseases.

H. Bismuth, R. Adam, D. Máthé, 1992, Clinica chimica acta; international journal of clinical chemistry.

Plasma lipids and apolipoproteins in end-stage liver disease.

H. Bismuth, R. Adam, D. Máthé, 1990, Clinica chimica acta; international journal of clinical chemistry.

Apolipoprotein C-II and C-III metabolism in a kindred of familial hypobetalipoproteinemia.

C. Malmendier, C. Delcroix, D. Dubois, 1991, Metabolism: clinical and experimental.

Plasma lipids, lipoproteins and apolipoproteins in two kindreds of hypobetalipoproteinemia.

C. Sérougne, J. Férézou, D. Máthé, 1990, Atherosclerosis.

Modifications of plasma lipids, lipoproteins and apolipoproteins in advanced cancer patients treated with recombinant interleukin-2 and autologous lymphokine-activated killer cells.

J. Sculier, C. Malmendier, D. Dubois, 1988, Atherosclerosis.

In vivo metabolism of apolipoproteins C-II and C-III in normal and hypertriglyceridemic subjects.

L. de Roy, T. Magot, C. Malmendier, 1988, Advances in experimental medicine and biology.

Effect of simvastatin on receptor-dependent low density lipoprotein catabolism in normocholesterolemic human volunteers.

T. Magot, C. Malmendier, C. Delcroix, 1989, Atherosclerosis.

Methylated amino acids in ribosomal proteins from Escherichia coli treated with ethionine and from a mutant lacking methylation of protein L11.

F. Lederer, A. Glatigny, C. Colson, 1979, Biochimie.

Turnover Studies of Apolipoproteins C: A First Critical Appraisal

C. Malmendier, J. Lontie, 1989 .

Prevalence of dyslipidemia in liver transplant recipients.

H. Bismuth, R. Adam, D. Máthé, 1992, Transplantation.

Conformational properties of apolipoproteins studied by computer graphics.

J. Kocher, C. Malmendier, C. Delcroix, 1991, Advances in experimental medicine and biology.

LDL binding to lipid emulsion particles: Effects of incubation duration, temperature, and addition of plasma subfractions

A. Gulik, Y. Carpentier, J. Férézou, 2002, Lipids.

Incubation of lipid emulsions with plasma lipoproteins modifies the fluidity of each particle

Y. Carpentier, C. Motta, J. Lontie, 2001, Lipids.

P.108 LDL binding to lipid emulsions is markedly influencedby the triglyceride fatty acid pattern of exogenous particles

A. Gulik, Y. Carpentier, J. Férézou, 1998 .

O.16 Triglyceride core of lipid emulsions modulatesthe acquisition of exchangeable plasma apolipoproteins (apos) in vitro

R. Deckelbaum, Y. Carpentier, J. Lontie, 1997 .

The mutagenicity in procaryotes of herbicides.

N. V. van Larebeke, J. Lontie, L. Schoofs, 1984, Residue reviews.

In vivo effect of simvastatin on lipoprotein cholesteryl ester metabolism in normocholesterolemic volunteers.

C. Lutton, K. Ouguerram, T. Magot, 1991, Clinica chimica acta; international journal of clinical chemistry.

Prediction of the tertiary structure of apolipoprotein A-II by computer modeling.

C. Malmendier, C. Delcroix, J. Lontie, 1988, Advances in experimental medicine and biology.

Abnormal lipoprotein and marked hypercholesterolemia as paraneoplastic manifestation of a renal adenocarcinoma.

Y. Carpentier, D. Dubois, J. Lontie, 2001, Atherosclerosis.